BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006; 12(23): 3682-3694 [PMID: 16773685 DOI: 10.3748/wjg.v12.i23.3682]
URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3682.htm
Number Citing Articles
1
AM Attallah, MS Albannan, MM Omran, R Zayed, S Saif, A Farid, M Hassany, A Yosry, D Omran. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosisBritish Journal of Biomedical Science 2019; 76(3): 105 doi: 10.1080/09674845.2019.1600325
2
Maria AL de Carli, Luiz A. de Carli, Marcos B. Correa, Gerson Junqueira, Cristiane Valle Tovo, Gabriela P. Coral. Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2020; 32(3): 420 doi: 10.1097/MEG.0000000000001519
3
Salimur Rahman, Mamun Al-Mahtab, Mohammad Sayedul Haque, Sharmin Sultana, Ayub Al-Mamun. The Value of Serum CA19-9 Levels in predicting Extent of Hepatic Fibrosis in Patients with Chronic Hepatitis BEuroasian Journal of Hepato-Gastroenterology 2015; 5(1): 16 doi: 10.5005/jp-journals-10018-1122
4
L.C. Mendes, P.A. Ferreira, N. Miotto, L. Zanaga, E. Gonçales, M.S. Lazarini, F.L. Gonçales Júnior, R.S.B. Stucchi, A.G. Vigani. Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis CBrazilian Journal of Medical and Biological Research 2016; 49(9) doi: 10.1590/1414-431x20165432
5
Yen Ngo, Yves Benhamou, Vincent Thibault, Patrick Ingiliz, Mona Munteanu, Pascal Lebray, Dominique Thabut, Rachel Morra, Djamila Messous, Frederic Charlotte, Françoise Imbert-Bismut, Dominique Rousselot-Bonnefont, Joseph Moussalli, Vlad Ratziu, Thierry Poynard, Niyaz Ahmed. An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral LoadPLoS ONE 2008; 3(7): e2573 doi: 10.1371/journal.pone.0002573
6
Ashraf Elfakhry, Ehab Abdel-Khalek, Sahar El-Gharabawy, Eman El-Tanaihy, Azza Abdelbaky. Predictive value of the adiponectin to leptin ratio for diagnosis of steatohepatitis in patients with nonalcoholic fatty liver diseaseEgyptian Liver Journal 2013; 3(2): 47 doi: 10.1097/01.ELX.0000427107.63804.34
7
Dalia Omran, Rania A. Zayed, Mohammed M. Nabeel, Lamiaa Mobarak, Zeinab Zakaria, Azza Farid, Mohamed Hassany, Sameh Saif, Muhammad Mostafa, Omar Khalid Saad, Ayman Yosry. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian PatientsViral Immunology 2018; 31(4): 315 doi: 10.1089/vim.2017.0134
8
Ferah Armutcu, Sumeyya Akyol, Fatma Ucar, Serpil Erdogan, Omer Akyol. Advances in Clinical Chemistry 2013; 61: 67 doi: 10.1016/B978-0-12-407680-8.00004-X
9
El-Shahat A. Toson, Gamal E. Shiha, Hatem A. El-mezayen, Waleed Samir, Mohamed M. El-khininy. Noninvasive estimation of liver fibrosis in biopsy-proven hepatitis C virus-infected patientsEuropean Journal of Gastroenterology & Hepatology 2017; 29(2): 199 doi: 10.1097/MEG.0000000000000775
10
Laurent Castera, Xavier Forns, Alfredo Alberti. Non-invasive evaluation of liver fibrosis using transient elastographyJournal of Hepatology 2008; 48(5): 835 doi: 10.1016/j.jhep.2008.02.008
11
Hüseyin Saadettin Uslusoy, Selim Giray Nak, Macit Gülten. Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitisWorld Journal of Hepatology 2011; 3(8): 219-227 doi: 10.4254/wjh.v3.i8.219
12
Flavia Bortolotti, Maria Guido. Reversal of Liver Cirrhosis: A Desirable Clinical Outcome and Its Pathogenic BackgroundJournal of Pediatric Gastroenterology & Nutrition 2007; 44(4): 401 doi: 10.1097/MPG.0b013e318032069a
13
Abdelfattah M. Attallah, Mohamed El-Far, Mohamed M. Omran, Khaled Farid, Mohamed S. Albannan, Ibrahim El-Dosoky. Noninvasive Diagnosis of Liver Fibrosis and Cirrhosis in Chronic Hepatitis C PatientsJournal of Clinical Laboratory Analysis 2013; 27(2): 121 doi: 10.1002/jcla.21572
14
Laurent Castéra, Giada Sebastiani, Brigitte Le Bail, Victor de Lédinghen, Patrice Couzigou, Alfredo Alberti. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis CJournal of Hepatology 2010; 52(2): 191 doi: 10.1016/j.jhep.2009.11.008
15
Thomas Pembroke, Giada Sebastiani. Diagnostic Methods for Cirrhosis and Portal Hypertension2018; : 63 doi: 10.1007/978-3-319-72628-1_5
16
Thierry Poynard, Rachel Morra, Philippe Halfon, Laurent Castera, Vlad Ratziu, Françoise Imbert-Bismut, Sylvie Naveau, Dominique Thabut, Didier Lebrec, Fabien Zoulim, Marc Bourliere, Patrice Cacoub, Djamila Messous, Mona Munteanu, Victor de Ledinghen. Meta-analyses of FibroTest diagnostic value in chronic liver diseaseBMC Gastroenterology 2007; 7(1) doi: 10.1186/1471-230X-7-40
17
Shallu Tomer, SunilK Arora. A juggernaut of innate & adaptive immune cells in chronic hepatitis CIndian Journal of Medical Research 2020; 151(4): 279 doi: 10.4103/ijmr.IJMR_1387_17
18
Philippe Halfon, Yannick Bacq, Anne De Muret, Guillaume Penaranda, Marc Bourliere, Denis Ouzan, Albert Tran, Danielle Botta, Christophe Renou, Marie-Claude Bréchot, Claude Degott, Valérie Paradis. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis CJournal of Hepatology 2007; 46(3): 395 doi: 10.1016/j.jhep.2006.09.020
19
Jayant A. Talwalkar, Meng Yin, Jeff L. Fidler, Schuyler O. Sanderson, Patrick S. Kamath, Richard L. Ehman. Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applicationsHepatology 2007; 47(1): 332 doi: 10.1002/hep.21972
20
M. Bourlière, G. Pénaranda, X. Adhoute, V. Oules, P. Castellani. Combining non-invasive methods for assessment of liver fibrosisGastroentérologie Clinique et Biologique 2008; 32(6): 73 doi: 10.1016/S0399-8320(08)73996-4
21
G. Sebastiani, A. Alberti. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?Journal of Viral Hepatitis 2012; 19: 18 doi: 10.1111/j.1365-2893.2011.01518.x
22
Henrique S. T. Correia, Ana Lucia C. Domingues, Edmundo P. A. Lopes, Clarice N. L. Morais, Camila Sarteschi, Izolda M. F. Moura. Níveis séricos de globulinas e a intensidade da fibrose hepática em pacientes com esquistossomose mansônicaArquivos de Gastroenterologia 2009; 46(3): 194 doi: 10.1590/S0004-28032009000300010
23
Waqar Ahmad, Bushra Ijaz, Sana Gull, Sultan Asad, Saba Khaliq, Shah Jahan, Muhammad T Sarwar, Humera Kausar, Aleena Sumrin, Imran Shahid, Sajida Hassan. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluationVirology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-53
24
Ju‐Seop Kang, Min‐Ho Lee. Liver Cirrhosis - Update and Current Challenges2017;  doi: 10.5772/intechopen.68317
25
Hüseyin Saadettin Uslusoy, Selim Giray Nak, Macit Gülten, Zeynep Bıyıklı. Non-alcoholic steatohepatitis with normal aminotransferase valuesWorld Journal of Gastroenterology 2009; 15(15): 1863-1868 doi: 10.3748/wjg.15.1863
26
Ramin Jafari, Stefanie J. Hectors, Anne K. Koehne de González, Pascal Spincemaille, Martin R. Prince, Gary M. Brittenham, Yi Wang. Integrated quantitative susceptibility and R 2 * mapping for evaluation of liver fibrosis: An ex vivo feasibility study NMR in Biomedicine 2021; 34(1) doi: 10.1002/nbm.4412
27
Wilma Debernardi-Venon, Silvia Martini, Fiorella Biasi, Barbara Vizio, Angela Termine, Giuseppe Poli, Franco Brunello, Carlo Alessandria, Renato Bonardi, Giorgio Saracco, Mario Rizzetto, Alfredo Marzano. AT1 receptor antagonist Candesartan in selected cirrhotic patients: Effect on portal pressure and liver fibrosis markersJournal of Hepatology 2007; 46(6): 1026 doi: 10.1016/j.jhep.2007.01.017
28
Ying Qu, Chun-Fang Gao, Kun Zhou, Yun-Peng Zhao, Ming-Yi Xu, Lun-Gen Lu. Serum N-glycomic markers in combination with panels improves the diagnosis of chronic hepatitis BAnnals of Hepatology 2012; 11(2): 202 doi: 10.1016/S1665-2681(19)31025-7
29
Laurent Castera, Jacques Denis, Gerard Babany, Françoise Roudot-Thoraval. Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: Time for new guidelines?Journal of Hepatology 2007; 46(3): 528 doi: 10.1016/j.jhep.2006.12.002
30
A. Maieron, P. Salzl, M. Peck-Radosavljevic, M. Trauner, S. Hametner, R. Schöfl, P. Ferenci, M. Ferlitsch. Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis CAlimentary Pharmacology & Therapeutics 2014; 39(3): 331 doi: 10.1111/apt.12564
31
Catherine Jane Messner, Saskia Schmidt, Dilek Özkul, Carine Gaiser, Luigi Terracciano, Stephan Krähenbühl, Laura Suter-Dick. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC ActivationInternational Journal of Molecular Sciences 2021; 22(18): 9799 doi: 10.3390/ijms22189799
32
Giada Sebastiani, Kostas Pantopoulos. Cellular and Molecular Biology of Metals2010; : 351 doi: 10.1201/9781420059984-c13
33
Rachel Morra, Mona Munteanu, Françoise Imbert-Bismut, Djamila Messous, Vlad Ratziu, Thierry Poynard. FibroMAX™: towards a new universal biomarker of liver disease?Expert Review of Molecular Diagnostics 2007; 7(5): 481 doi: 10.1586/14737159.7.5.481
34
Pierre Brissot, Marie-Bérengère Troadec, Edouard Bardou-Jacquet, Caroline Le Lan, Anne-Marie Jouanolle, Yves Deugnier, Olivier Loréal. Current approach to hemochromatosisBlood Reviews 2008; 22(4): 195 doi: 10.1016/j.blre.2008.03.001
35
Cumali Efe, Mustafa Cengiz, Evrim Kahramanoğlu-Aksoy, Bülent Ylmaz, Burak Özşeker, Yavuz Beyazt, Alpaslan Tanoğlu, Tugrul Purnak, Taylan Kav, Turan Turhan, Seren Ozenirler, Ersan Ozaslan, Staffan Wahlin. Angiotensin-converting enzyme for noninvasive assessment of liver fibrosis in autoimmune hepatitisEuropean Journal of Gastroenterology & Hepatology 2015; 27(6): 649 doi: 10.1097/MEG.0000000000000355
36
Eylem Levelt, Michael Pavlides, Rajarshi Banerjee, Masliza Mahmod, Catherine Kelly, Joanna Sellwood, Rina Ariga, Sheena Thomas, Jane Francis, Christopher Rodgers, William Clarke, Nikant Sabharwal, Charalambos Antoniades, Jurgen Schneider, Matthew Robson, Kieran Clarke, Theodoros Karamitsos, Oliver Rider, Stefan Neubauer. Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 DiabetesJournal of the American College of Cardiology 2016; 68(1): 53 doi: 10.1016/j.jacc.2016.03.597
37
G. Sebastiani, A. Vario, M. Guido, A. Alberti. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminasesJournal of Viral Hepatitis 2007; 15(3): 212 doi: 10.1111/j.1365-2893.2007.00932.x
38
Mohammed Abd El-Hamid El-Bokl, Shadia Mabrouk, Nanees Ahmed Adel Abd El-Mageed, Nermine Helmy Mahmoud, Sherif Sadek Shabana. Do serum CA 19-9 and CA 125 levels predict the severity of HCV-related liver fibrosis?Egyptian Liver Journal 2011; 1(1): 33 doi: 10.1097/01.ELX.0000397025.95176.ca
39
José Tadeu Stefano, Laura Vilar Guedes, Arthur Alencar Arrais de Souza, Denise Siqueira Vanni, Venâncio Avancini Ferreira Alves, Flair José Carrilho, Alvaro Largura, Marco Arrese, Claudia P. Oliveira. Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver diseaseAnnals of Hepatology 2021; 20: 100253 doi: 10.1016/j.aohep.2020.08.070
40
Jordi Camps, Judit Marsillach, Jorge Joven. The paraoxonases: role in human diseases and methodological difficulties in measurementCritical Reviews in Clinical Laboratory Sciences 2009; 46(2): 83 doi: 10.1080/10408360802610878
41
A. Cequera, M.C. García de León Méndez. Biomarkers for liver fibrosis: Advances, advantages and disadvantagesRevista de Gastroenterología de México (English Edition) 2014; 79(3): 187 doi: 10.1016/j.rgmxen.2014.07.001
42
Vasiliy Ivanovich Reshetnyak. Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosisWorld Journal of Gastroenterology 2015; 21(25): 7683-7708 doi: 10.3748/wjg.v21.i25.7683
43
Gamal Shiha, Nasser Mousa. Liver Diseases2020; : 427 doi: 10.1007/978-3-030-24432-3_36
44
Minjie Wan, Hongqin Xu, Dezhao Li, Le Wang, Xu Li. Accuracy of gamma-glutamyl transpeptidase-to-platelet ratio (GPR), red cell distribution width (RDW), aspartate aminotransferase-to-platelet ratio index (APRI), and the fibrosis-4 index (FIB4) compared with liver biopsy in patients with drug-induced liver injury (DILI)Medicine 2021; 100(6): e24723 doi: 10.1097/MD.0000000000024723
45
Saurabh Sethi, Douglas A Simonetto, Soha S Abdelmoneim, Michael B Campion, Irakli Kaloiani, Amy C Clayton, Walter K Kremers, Kevin C Halling, Patrick S Kamath, Jayant Talwalkar, Vijay H Shah. Comparison of Circulating Endothelial Cell/Platelet Count Ratio to Aspartate Transaminase/Platelet Ratio Index for Identifying Patients with CirrhosisJournal of Clinical and Experimental Hepatology 2012; 2(1): 19 doi: 10.1016/S0973-6883(12)60078-4
46
Daiki Suzuki, Koyo Yu, Kouhei Ohnishi. A quantitative stiffness assessment method in liver biopsy teleoperationsIECON 2013 - 39th Annual Conference of the IEEE Industrial Electronics Society 2013; : 3281 doi: 10.1109/IECON.2013.6699654
47
Mustafa Cengiz, Seren Ozenirler, Sehri Elbeg. Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosisJournal of Gastroenterology and Hepatology 2015; 30(7): 1190 doi: 10.1111/jgh.12924
48
Mônica Salum Valverde Borsoi Viana, Kioko Takei, Diva Carvalho Collarile Yamaguti, Betty Guz, Edna Strauss. Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis CAnnals of Hepatology 2009; 8(1): 26 doi: 10.1016/S1665-2681(19)31807-1
49
Vincent Leroy, Philippe Halfon, Yannick Bacq, Jérôme Boursier, Marie Christine Rousselet, Marc Bourlière, Anne de Muret, Nathalie Sturm, Gilles Hunault, Guillaume Penaranda, Marie-Claude Bréchot, Candice Trocme, Paul Calès. Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: A meta-analysis with individual dataClinical Biochemistry 2008; 41(16-17): 1368 doi: 10.1016/j.clinbiochem.2008.06.020
50
Abdel Aziz M. Shaheen, Alex F. Wan, Robert P. Myers. FibroTest and FibroScan for the Prediction of Hepatitis C-Related Fibrosis: A Systematic Review of Diagnostic Test AccuracyThe American Journal of Gastroenterology 2007; 102(11): 2589 doi: 10.1111/j.1572-0241.2007.01466.x
51
Hind I. Fallatah. Noninvasive Biomarkers of Liver Fibrosis: An OverviewAdvances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/357287
52
Elham Ahmed Hassan, Abeer Sharaf El-Din Abd El-Rehim, Zain El-Abdeen Ahmed Sayed, Emad Farah Mohamed Kholef, Abeer Sabry, Noha Abd El-Rehim Abo Elhagag. VAP score as a novel non-invasive liver fibrosis model in patients with chronic hepatitis CHepatology Research 2017; 47(13): 1408 doi: 10.1111/hepr.12884
53
Jia Cai, Maria Osikowicz, Giada Sebastiani. Clinical significance of elevated liver transaminases in HIV-infected patientsAIDS 2019; 33(8): 1267 doi: 10.1097/QAD.0000000000002233
54
J. Marsillach, S. Parra, N. Ferré, B. Coll, C. Alonso-Villaverde, J. Joven, J. Camps. The Paraoxonases: Their Role in Disease Development and Xenobiotic MetabolismProteins And Cell Regulation 2008; 6: 187 doi: 10.1007/978-1-4020-6561-3_12
55
Laurent Castera. Non-invasive assessment of liver fibrosis in chronic hepatitis CHepatology International 2011; 5(2): 625 doi: 10.1007/s12072-010-9240-0
56
Evangelos Cholongitas, Emmanouel Tsochatzis, John Goulis, Andrew K. Burroughs. Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic reviewTransplant International 2010; 23(9): 861 doi: 10.1111/j.1432-2277.2010.01142.x
57
Ki M. Mak, Rena Mei. Basement Membrane Type IV Collagen and Laminin: An Overview of Their Biology and Value as Fibrosis Biomarkers of Liver DiseaseThe Anatomical Record 2017; 300(8): 1371 doi: 10.1002/ar.23567
58
Richard S. Mangus, Michael G. O'Connor, A. Joseph Tector, Joel D. Lim, Rodrigo M. Vianna. Use of the aspartate aminotransferase to platelet ratio index to follow liver fibrosis progression in infants with short gutJournal of Pediatric Surgery 2010; 45(6): 1266 doi: 10.1016/j.jpedsurg.2010.02.098
59
Antonio Colecchia, Giovanni Marasco, Martina Taddia, Lucia Montrone, Leonardo H. Eusebi, Daniele Mandolesi, Ramona Schiumerini, Anna R. Di Biase, Davide Festi. Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patientsEuropean Journal of Gastroenterology & Hepatology 2015; 27(9): 992 doi: 10.1097/MEG.0000000000000393
60
Paul Calès, Fabrice Lainé, Jérôme Boursier, Yves Deugnier, Valérie Moal, Frédéric Oberti, Gilles Hunault, Marie Christine Rousselet, Isabelle Hubert, Jihane Laafi, Pierre Henri Ducluzeaux, Françoise Lunel. Comparison of blood tests for liver fibrosis specific or not to NAFLDJournal of Hepatology 2009; 50(1): 165 doi: 10.1016/j.jhep.2008.07.035
61
Bo Zhu, Siu-Lung Chan, Jack Li, Kathryn Li, Hao Wu, Kui Cui, Hong Chen. Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and TreatmentFrontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.742382
62
A. Biasiolo, L. Chemello, S. Quarta, L. Cavalletto, F. Bortolotti, C. Caberlotto, L. Beneduce, E. Bernardinello, N. Tono, G. Fassina, A. Gatta, P. Pontisso. Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitisJournal of Viral Hepatitis 2008; 15(4): 246 doi: 10.1111/j.1365-2893.2007.00935.x
63
Maria Guido. Practical Hepatic Pathology: A Diagnostic Approach2011; : 201 doi: 10.1016/B978-0-443-06803-4.00016-2
64
Ángel Palacios Pérez, Javier Salmerón Escobar. Papel de la biopsia hepática en el diagnóstico y el control de la hepatitis C crónicaGastroenterología y Hepatología 2007; 30(7): 402 doi: 10.1157/13108806
65
Mireen Friedrich–Rust, Mei–Fang Ong, Swantje Martens, Christoph Sarrazin, Joerg Bojunga, Stefan Zeuzem, Eva Herrmann. Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-AnalysisGastroenterology 2008; 134(4): 960 doi: 10.1053/j.gastro.2008.01.034
66
Paul Calès, Victor De Ledinghen, Philippe Halfon, Yannick Bacq, Vincent Leroy, Jérôme Boursier, Juliette Foucher, Marc Bourlière, Anne De Muret, Nathalie Sturm, Gilles Hunault, Frédéric Oberti. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis CLiver International 2008; 28(10): 1352 doi: 10.1111/j.1478-3231.2008.01789.x
67
Maria Kalafateli, Kurinchi Selvan Gurusamy, Anna H Noel-Storr, Andrew K Burroughs, Emmanuel Tsochatzis. Forns index and 'FIB4' for staging of fibrosis in adults with chronic hepatitis CCochrane Database of Systematic Reviews 2015;  doi: 10.1002/14651858.CD011929
68
Hong-Bo Liu, Jian-Ping Zhou, Yong Zhang, Xiao-Hui Lv, Wei Wang. Prediction on liver fibrosis using different APRI thresholds when patient age is a categorical marker in patients with chronic hepatitis BClinica Chimica Acta 2011; 412(1-2): 33 doi: 10.1016/j.cca.2010.08.032
69
Basem Hasan Elesawy, Amal Abd El hafez, Laila Shehata Dorgham, Ahmad El-Askary. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoringPathology - Research and Practice 2014; 210(12): 922 doi: 10.1016/j.prp.2014.07.005
70
G. Sebastiani, L. Castera, P. Halfon, S. Pol, A. Mangia, V. Di Marco, M. Pirisi, M. Voiculescu, M. Bourliere, A. Alberti. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 casesAlimentary Pharmacology & Therapeutics 2011; 34(10): 1202 doi: 10.1111/j.1365-2036.2011.04861.x
71
Nikolaos K. Gatselis, George Ntaios, Konstantinos Makaritsis, George N. Dalekos. Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver diseaseClinical and Experimental Medicine 2014; 14(2): 121 doi: 10.1007/s10238-012-0227-0
72
Steven Shinn-Forng Peng, Yung-Ming Jeng, Wen-Ming Hsu, Justin Cheng-Ta Yang, Ming-Chih Ho. Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patientsEuropean Radiology 2015; 25(10): 2992 doi: 10.1007/s00330-015-3716-1
73
Tianhui Liu, Xiaoming Wang, Morten A. Karsdal, Diana J. Leeming, Federica Genovese. Molecular Serum Markers of Liver FibrosisBiomarker Insights 2012; 7: BMI.S10009 doi: 10.4137/BMI.S10009
74
Laurent Castera. Cirrhosis: A practical guide to management2015; : 53 doi: 10.1002/9781118412640.ch06
75
Thierry Poynard, Rachel Morra, Patrick Ingiliz, Françoise Imbert‐Bismut, Dominique Thabut, Djamila Messous, Mona Munteanu, Julien Massard, Yves Benhamou, Vlad Ratziu. Advances in Clinical Chemistry 2008; 46: 131 doi: 10.1016/S0065-2423(08)00404-6
76
P. Calès, J. Boursier, V. de Lédinghen, P. Halfon, Y. Bacq, V. Leroy, N. Dib, F. Oberti, A. Sawadogo, M.-C. Rousselet, F. Lunel. Evaluation and improvement of a reliable diagnosis of cirrhosis by blood testsGastroentérologie Clinique et Biologique 2008; 32(12): 1050 doi: 10.1016/j.gcb.2008.09.017
77
Laurent Castera. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitisJournal of Viral Hepatitis 2009; 16(5): 300 doi: 10.1111/j.1365-2893.2009.01087.x
78
Lidia Monti, Marco Salsano, Manila Candusso, Alfonso Wolfango Avolio, Giovanna Soglia, Marzia Marino, Paola Francalanci, Marco Spada, Paolo Toma. Diagnosis of Acute Rejection of Liver Grafts in Young Children Using Acoustic Radiation Force Impulse ImagingAmerican Journal of Roentgenology 2020; 215(5): 1229 doi: 10.2214/AJR.19.22057
79
P. Bonnard, A. Elsharkawy, K. Zalata, E. Delarocque-Astagneau, L. Biard, L. Le Fouler, A. B. Hassan, M. Abdel-Hamid, M. El-Daly, M. E. Gamal, M. El Kassas, P. Bedossa, F. Carrat, A. Fontanet, G. Esmat. Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in EgyptJournal of Viral Hepatitis 2015; 22(3): 245 doi: 10.1111/jvh.12285
80
Joseph Misdraji. Changing indications for liver biopsy: viral hepatitisDiagnostic Histopathology 2014; 20(3): 119 doi: 10.1016/j.mpdhp.2014.01.010
81
Giada Sebastiani, Konstantinos Gkouvatsos, Kostas Pantopoulos. Chronic hepatitis C and liver fibrosisWorld Journal of Gastroenterology 2014; 20(32): 11033-11053 doi: 10.3748/wjg.v20.i32.11033
82
Huseyin Kayadibi, Bulent Yasar, Selvinaz Ozkara, Muhittin A. Serdar, Oya O. Kurdas, Can Gonen. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosisScandinavian Journal of Clinical and Laboratory Investigation 2014; 74(3): 240 doi: 10.3109/00365513.2013.879392
83
Shuai Gao, Xin-You Li, Yu-Chen Fan, Feng-Kai Sun, Li-Yan Han, Feng Li, Xiang-Fen Ji, Kai Wang. A noninvasive model to predict liver histology in HBeAg-positive chronic hepatitis B with alanine aminotransferase ≤ 2upper limit of normalJournal of Gastroenterology and Hepatology 2017; 32(1): 215 doi: 10.1111/jgh.13452
84
Tarek A Besheer, Mahmoud M El-Bendary, Khaled R Zalata, Hossam E Zaghalol. Evaluation of Fibrosis Progression by Noninvasive Biochemical Markers in Egyptian Patients with Chronic Hepatitis BEuroasian Journal of Hepato-Gastroenterology 2011; 1(2): 71 doi: 10.5005/jp-journals-10018-1016
85
Manuela G. Neuman, Hemda Schmilovitz-Weiss, Nir Hilzenrat, Marc Bourliere, Patrick Marcellin, Cristhian Trepo, Tony Mazulli, George Moussa, Ankit Patel, Asad A. Baig, Lawrence Cohen. Markers of Inflammation and Fibrosis in Alcoholic Hepatitis and Viral Hepatitis CInternational Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/231210
86
Zoran Stankovic. Four-dimensional flow magnetic resonance imaging in cirrhosisWorld Journal of Gastroenterology 2016; 22(1): 89-102 doi: 10.3748/wjg.v22.i1.89
87
G. Sebastiani, P. Halfon, L. Castera, A. Mangia, V. Di Marco, M. Pirisi, M. Voiculescu, M. Bourliere, A. Alberti. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis CAlimentary Pharmacology & Therapeutics 2012; 35(1): 92 doi: 10.1111/j.1365-2036.2011.04897.x
88
Urpo Nieminen, Perttu E. T. Arkkila, Päivi Kärkkäinen, Martti A. Färkkilä. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis CLiver International 2009; 29(2): 153 doi: 10.1111/j.1478-3231.2008.01779.x
89
Ahmed Abdel Khalek Abdel Razek, Ahmed Abdalla, Eman Omran, Abeer Fathy, Khaled Zalata. Diagnosis and quantification of hepatic fibrosis in children with diffusion weighted MR imagingEuropean Journal of Radiology 2011; 78(1): 129 doi: 10.1016/j.ejrad.2009.10.012
90
Dirk J. Van Leeuwen, Charles Balabaud, James M. Crawford, Paulette Bioulac–Sage, Amar P. Dhillon. A Clinical and Histopathologic Perspective on Evolving Noninvasive and Invasive Alternatives for Liver BiopsyClinical Gastroenterology and Hepatology 2008; 6(5): 491 doi: 10.1016/j.cgh.2008.02.023
91
Jérôme Boursier, Yannick Bacq, Philippe Halfon, Vincent Leroy, Victor de Ledinghen, Anne de Muret, Marc Bourlière, Nathalie Sturm, Juliette Foucher, Frédéric Oberti, Marie Christine Rousselet, Paul Calès. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis CEuropean Journal of Gastroenterology & Hepatology 2009; 21(1): 28 doi: 10.1097/MEG.0b013e32830cebd7
92
Henry L-Y Chan, H Janaka de Silva, Nancy W-Y Leung, Seng-Gee Lim, Geoffrey C Farrell. How should we manage patients with non-alcoholic fatty liver disease in 2007?Journal of Gastroenterology and Hepatology 2007; 22(6): 801 doi: 10.1111/j.1440-1746.2007.04977.x
93
Tamer F. Taha Ali, Mona AbdelGhaffar El Hariri. Diffusion-weighted MRI in liver fibrosis staging: Added value of normalized ADC using spleen and renal cortex as reference organsThe Egyptian Journal of Radiology and Nuclear Medicine 2017; 48(1): 23 doi: 10.1016/j.ejrnm.2016.11.004
94
Hatem A. El-Mezayen, Salem Habib, Hamdi F. Marzok, Mostafa H. Saad. Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patientsEuropean Journal of Gastroenterology & Hepatology 2015; 27(4): 378 doi: 10.1097/MEG.0000000000000298
95
Vlad Pădureanu, Dalia Dop, Alice Drăgoescu, Rodica Pădureanu, Anca Mușetescu, Laurențiu Nedelcu. Non‑alcoholic fatty liver disease and hematologic manifestations (Review)Experimental and Therapeutic Medicine 2021; 22(6) doi: 10.3892/etm.2021.10790
96
Abdel Aziz M. Shaheen, Robert P. Myers. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C–related fibrosis: A systematic reviewHepatology 2007; 46(3): 912 doi: 10.1002/hep.21835
97
G. Shiha, S. Seif, A. Eldesoky, M. Elbasiony, R. Soliman, A. Metwally, K. Zalata, N. Mikhail. A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis CHepatology International 2017; 11(3): 286 doi: 10.1007/s12072-017-9796-z
98
Giada Sebastiani, Konstantinos Gkouvatsos, Mario Plebani. Non-invasive assessment of liver fibrosis: it is time for laboratory medicineClinical Chemistry and Laboratory Medicine 2011; 49(1) doi: 10.1515/CCLM.2011.001
99
Marwa K. Ibrahim, Hosny Salama, Mohamad Abd El Rahman, Reham M. Dawood, Noha G. Bader El Din, Heba F. Salem, Mohamed E.A. Abdelrahim, Dalia Omran, Moataza H. Omran, Khaled Helmi El-Wakeel, Tawfeek H. Abdelhafez, Ahmed Khedr, Mostafa K. El Awady. Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus PatientsJournal of Interferon & Cytokine Research 2016; 36(12): 698 doi: 10.1089/jir.2016.0042
100
Ana Lúcia Coutinho Domingues, Tibério Batista de Medeiros, Edmundo Pessoa de Almeida Lopes. Ultrasound versus biological markers in the evaluation of periportal fibrosis in human Schistosoma mansoniMemórias do Instituto Oswaldo Cruz 2011; 106(7): 802 doi: 10.1590/S0074-02762011000700004
101
Giada Sebastiani. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithmsWorld Journal of Gastroenterology 2009; 15(18): 2190-2203 doi: 10.3748/wjg.15.2190
102
Mustafa Cengiz, Seren Ozenirler, Murat Kocabiyik. Serum β-trophin level as a new marker for noninvasive assessment of nonalcoholic fatty liver disease and liver fibrosisEuropean Journal of Gastroenterology & Hepatology 2016; 28(1): 57 doi: 10.1097/MEG.0000000000000502
103
T. POYNARD, P. HALFON, L. CASTERA, F. CHARLOTTE, B. LE BAIL, M. MUNTEANU, D. MESSOUS, V. RATZIU, Y. BENHAMOU, M. BOURLIÈRE, V. DE LEDINGHEN. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentationAlimentary Pharmacology & Therapeutics 2007; 25(6): 733 doi: 10.1111/j.1365-2036.2007.03252.x
104
Diana Joka, Kristin Wahl, Sarah Moeller, Jerome Schlue, Bernhard Vaske, Matthias J. Bahr, Michael P. Manns, Klaus Schulze-Osthoff, Heike Bantel. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitisHepatology 2012; 55(2): 455 doi: 10.1002/hep.24734
105
Yong-Peng Chen, Xie-Er Liang. Non-invasive assessment of liver fibrosis: reduce or substitute the need for liver biopsy?Liver International 2015; 35(11): 2483 doi: 10.1111/liv.12824
106
Argiro Voumvouraki, Mairi Koulentaki, George Notas, Ourania Sfakianaki, Elias Kouroumalis. Serum surrogate markers of liver fibrosis in primary biliary cirrhosisEuropean Journal of Internal Medicine 2011; 22(1): 77 doi: 10.1016/j.ejim.2010.10.002
107
Abdelfattah M. Attallah, Mohamed M. Omran, Khaled Farid, Mahmoud El-Bendary, Tarek M. Emran, Mohamed S. Albannan, Ibrahim El-Dosoky. Development of a novel score for liver fibrosis staging and comparison with eight simple laboratory scores in large numbers of HCV-monoinfected patientsClinica Chimica Acta 2012; 413(21-22): 1725 doi: 10.1016/j.cca.2012.06.031
108
Reham M. Dawood, Mai Abd el-Meguid, Marwa K. Ibrahim, Noha G. Bader El Din, Ahmed Barakat, Khaled El-Wakeel, Mohamed Darwish Ahmed Abd Alla, George Y. Wu, Mostafa K. El Awady. Dysregulation of fibrosis related genes in HCV induced liver diseaseGene 2018; 664: 58 doi: 10.1016/j.gene.2018.04.032
109
Xiaolong Qi, Min An, Tongwei Wu, Deke Jiang, Mengyun Peng, Weidong Wang, Jing Wang, Chunqing Zhang, on behalf of the CHESS Study Group. Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-AnalysisCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/3406789
110
Nermin N Salkic, Predrag Jovanovic, Goran Hauser, Majda Brcic. FibroTest/Fibrosure for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-AnalysisAmerican Journal of Gastroenterology 2014; 109(6): 796 doi: 10.1038/ajg.2014.21
111
Laurent Castera. Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or CGastroenterology 2012; 142(6): 1293 doi: 10.1053/j.gastro.2012.02.017
112
A. Cequera, M.C. García de León Méndez. Biomarcadores para fibrosis hepática, avances, ventajas y desventajasRevista de Gastroenterología de México 2014; 79(3): 187 doi: 10.1016/j.rgmx.2014.05.003
113
Mohammad Reza Raoufy, Parviz Vahdani, Seyed Moayed Alavian, Sahba Fekri, Parivash Eftekhari, Shahriar Gharibzadeh. A Novel Method for Diagnosing Cirrhosis in Patients with Chronic Hepatitis B: Artificial Neural Network ApproachJournal of Medical Systems 2011; 35(1): 121 doi: 10.1007/s10916-009-9348-8
114
Thierry Poynard, Patrick Ingiliz, Laure Elkrief, Mona Munteanu, Pascal Lebray, Rachel Morra, Djamila Messous, Francoise Imbert Bismut, Dominique Roulot, Yves Benhamou, Dominique Thabut, Vlad Ratziu, Ji Zhu. Concordance in a World without a Gold Standard: A New Non-Invasive Methodology for Improving Accuracy of Fibrosis MarkersPLoS ONE 2008; 3(12): e3857 doi: 10.1371/journal.pone.0003857
115
Giada Sebastiani, Philippe Halfon, Laurent Castera, Stanislas Pol, David L. Thomas, Alessandra Mangia, Vito Di Marco, Mario Pirisi, Mihai Voiculescu, Maria Guido, Marc Bourliere, Franco Noventa, Alfredo Alberti. SAFE biopsy: A validated method for large-scale staging of liver fibrosis in chronic hepatitis CHepatology 2009; 49(6): 1821 doi: 10.1002/hep.22859
116
Carlo Fabris, Carlo Smirne, Pierluigi Toniutto, Cosimo Colletta, Rachele Rapetti, Rosalba Minisini, Edmondo Falleti, Monica Leutner, Mario Pirisi. Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis CClinical Chemical Laboratory Medicine 2008; 46(2) doi: 10.1515/CCLM.2008.051
117
Wei Liu, Xiaosong Li, Weihong Zheng, Rucheng Yao, Jun Zheng. Preoperative evaluation of the degree of liver fibrosis based on matter-element analysis using serological indicators in patients with hepatocellular carcinomaBioScience Trends 2019; 13(1): 70 doi: 10.5582/bst.2018.01311
118
Kristin Wahl, William Rosenberg, Bernhard Vaske, Michael P. Manns, Klaus Schulze-Osthoff, Matthias J. Bahr, Heike Bantel, Matias A. Avila. Biopsy-Controlled Liver Fibrosis Staging Using the Enhanced Liver Fibrosis (ELF) Score Compared to Transient ElastographyPLoS ONE 2012; 7(12): e51906 doi: 10.1371/journal.pone.0051906
119
Pamela Valva, Paola Casciato, Juan M. Diaz Carrasco, Adrian Gadano, Omar Galdame, María Cristina Galoppo, Eduardo Mullen, Elena De Matteo, María Victoria Preciado, Ravi Jhaveri. The Role of Serum Biomarkers in Predicting Fibrosis Progression in Pediatric and Adult Hepatitis C Virus Chronic InfectionPLoS ONE 2011; 6(8): e23218 doi: 10.1371/journal.pone.0023218
120
Maria Papastamataki, Polyxeni Delaporta, Evangelos Premetis, Antonios Kattamis, Vassilios Ladis, Ioannis Papassotiriou. Evaluation of liver fibrosis in patients with thalassemia: The important role of hyaluronic acidBlood Cells, Molecules, and Diseases 2010; 45(3): 215 doi: 10.1016/j.bcmd.2010.06.002
121
O.A. Gressner, R. Weiskirchen, A.M. Gressner. Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and realityJournal of Cellular and Molecular Medicine 2007; 11(5): 1031 doi: 10.1111/j.1582-4934.2007.00092.x
122
EL-Shahat A. Toson, Gamal E. Shiha, Asmaa E. Abdelgaleel. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian PatientsAnnals of Hepatology 2017; 16(6): 862 doi: 10.5604/01.3001.0010.5276
123
Oluwole S. Owojuyigbe, Christopher Larbie, Caleb K. Firempong, Gustav Komlaga, Benjamin O. Emikpe, Ademola A. Oyagbemi. Hura crepitans stem bark extract: A potential remedy to sub-acute liver damageJournal of Ethnopharmacology 2022; 284: 114768 doi: 10.1016/j.jep.2021.114768
124
M. Bourlière, A. Kahloun, G. Gascou-Tessonnier. Analogs and fibrosis regression in hepatitis BGastroentérologie Clinique et Biologique 2009; 33(10-11): 923 doi: 10.1016/j.gcb.2009.06.003
125
Fatma Demet Arslan, Inanc Karakoyun, Bengu Tatar, Emel Ebru Pala, Mustafa Yıldırım, Celal Ulasoglu, Can Duman, Harun Akar, Sukran Kose, Banu Isbilen Basok. SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis BHepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.63310
126
Grazia Pennisi, Antonina Giammanco, Salvatore Petta. Elastography of the Liver and Beyond2021; : 61 doi: 10.1007/978-3-030-74132-7_5
127
Pamela Valva, Daniela A Ríos, Elena De Matteo, Maria V Preciado. Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damageWorld Journal of Gastroenterology 2016; 22(4): 1367-1381 doi: 10.3748/wjg.v22.i4.1367
128
Paul Calès, Pascal Veillon, Anselme Konaté, Elisabeth Mathieu, Catherine Ternisien, Alain Chevailler, Alban Godon, Yves Gallois, Françoise Joubaud, Isabelle Hubert-Fouchard, Frédéric Oberti, Stéphane Réaud, Gilles Hunault, Françoise Mauriat, Françoise Lunel-Fabiani. Reproducibility of blood tests of liver fibrosis in clinical practiceClinical Biochemistry 2008; 41(1-2): 10 doi: 10.1016/j.clinbiochem.2007.08.009
129
Ki M. Mak, Chien Yi M. Png, Danielle J. Lee. Type V Collagen in Health, Disease, and FibrosisThe Anatomical Record 2016; 299(5): 613 doi: 10.1002/ar.23330
130
Mona El-Hariri, Tamer F. Taha Ali, Hala I.M. Hussien. Apparent diffusion coefficient (ADC) in liver fibrosis: Usefulness of normalized ADC using the spleen as reference organThe Egyptian Journal of Radiology and Nuclear Medicine 2013; 44(3): 441 doi: 10.1016/j.ejrnm.2013.05.008
131
Leah M. Norona, Deborah G. Nguyen, David A. Gerber, Sharon C. Presnell, Edward L. LeCluyse. Editor’s Highlight: Modeling Compound-Induced FibrogenesisIn VitroUsing Three-Dimensional Bioprinted Human Liver TissuesToxicological Sciences 2016; 154(2): 354 doi: 10.1093/toxsci/kfw169
132
Seung Kak Shin, Jeong Han Kim, Hyeonsu Park, Oh Sang Kwon, Hyun Jung Lee, Jong Eun Yeon, Kwan Soo Byun, Sang Jun Suh, Hyung Joon Yim, Yun Soo Kim, Ju Hyun Kim. Improvement of liver function and non-invasive fibrosis markers in hepatitis B virus-associated cirrhosis: 2 years of entecavir treatmentJournal of Gastroenterology and Hepatology 2015; 30(12): 1775 doi: 10.1111/jgh.13020
133
Gian Paolo Caviglia, Alessia Ciancio, Chiara Rosso, Maria Lorena Abate, Antonella Olivero, Rinaldo Pellicano, Giovanni Antonio Touscoz, Antonina Smedile, Mario Rizzetto. Non-invasive methods for the assessment of hepatic fibrosis: transient elastography, hyaluronic acid, 13C-aminopyrine breath test and cytokeratin 18 fragmentAnnals of Hepatology 2014; 13(1): 91 doi: 10.1016/S1665-2681(19)30909-3
134
Kin Jip Cheung, Kelly Tilleman, Dieter Deforce, Isabelle Colle, Hans Van Vlierberghe. Proteomics in liver fibrosis is more than meets the eyeEuropean Journal of Gastroenterology & Hepatology 2008; 20(5): 450 doi: 10.1097/MEG.0b013e3282f4de92
135
T. Poynard, M. Muntenau, R. Morra, Y. Ngo, F. Imbert-Bismut, D. Thabut, D. Messous, J. Massard, P. Lebray, J. Moussalli, Y. Benhamou, V. Ratziu. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 updateGastroentérologie Clinique et Biologique 2008; 32(6): 8 doi: 10.1016/S0399-8320(08)73990-3
136
Laurent Castera. Viral Hepatitis2013; : 341 doi: 10.1002/9781118637272.ch23
137
Mireen Friedrich-Rust, William Rosenberg, Julie Parkes, Eva Herrmann, Stefan Zeuzem, Christoph Sarrazin. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosisBMC Gastroenterology 2010; 10(1) doi: 10.1186/1471-230X-10-103
138
Pamela Valva, Paola Casciato, Carol Lezama, Marcela Galoppo, Adrián Gadano, Omar Galdame, María Cristina Galoppo, Eduardo Mullen, Elena De Matteo, María Victoria Preciado, Ravi Jhaveri. Serum Apoptosis Markers Related to Liver Damage in Chronic Hepatitis C: sFas as a Marker of Advanced Fibrosis in Children and Adults While M30 of Severe Steatosis Only in ChildrenPLoS ONE 2013; 8(1): e53519 doi: 10.1371/journal.pone.0053519
139
Václav Ceplecha, Kristína Řeháková, Corinne Lendon, Pavel Proks, Miša Škorič, Guy C.M. Grinwis, Barbora Hřibová, Miloš Vávra, Jana Lorenzová, Michal Crha. Hyaluronic acid and TGF-β1 in dogs with hepatobiliary diseasesActa Veterinaria Brno 2018; 87(3): 231 doi: 10.2754/avb201887030231
140
Tamara Alempijevic, Miodrag Krstic, Rada Jesic, Ivan Jovanovic, Aleksandra Sokic Milutinovic, Nada Kovacevic, Slobodan Krstic, Dragan Popovic. Biochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosisWorld Journal of Gastroenterology 2009; 15(5): 591-594 doi: 10.3748/wjg.15.591
141
Laurent Castéra, Brigitte Le Bail, Françoise Roudot-Thoraval, Pierre-Henri Bernard, Juliette Foucher, Wassil Merrouche, Patrice Couzigou, Victor de Lédinghen. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scoresJournal of Hepatology 2009; 50(1): 59 doi: 10.1016/j.jhep.2008.08.018
142
El-Shatat A. Toson, Gamal E. Shiha, Hatem A. El-Mezayen, Aml M. El-Sharkawy. Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patientsEuropean Journal of Gastroenterology & Hepatology 2016; 28(8): 931 doi: 10.1097/MEG.0000000000000656
143
Evangelos Cholongitas, Andrew K Burroughs, Amar P Dhillon. Evidence‐Based Gastroenterology and Hepatology2010; : 762 doi: 10.1002/9781444314403.ch46
144
Ching-Sheng Hsu, Jia-Horng Kao. Non-alcoholic fatty liver disease: An emerging liver disease in TaiwanJournal of the Formosan Medical Association 2012; 111(10): 527 doi: 10.1016/j.jfma.2012.07.002
145
Giada Sebastiani, Alfredo Alberti. Non-invasive markers of liver fibrosis: How to use them in clinical practice?Journal of Hepatology 2007; 46(3): 529 doi: 10.1016/j.jhep.2006.12.003
146
Andrew K. Burroughs, Evangelos Cholongitas. Non-invasive tests for liver fibrosis: Encouraging or discouraging results?Journal of Hepatology 2007; 46(5): 751 doi: 10.1016/j.jhep.2007.02.017
147
An-Na Pan, Wang-Wang Xu, Yun-Lin Luo, Huan-Huan Yu, Yi-Bing Hu, Qing-Feng Sun, Ji-Guang Ding, Yang-He Wu. A novel system for predicting liver histopathology in patients with chronic hepatitis BMedicine 2017; 96(14): e6465 doi: 10.1097/MD.0000000000006465
148
Catherine Jane Messner, Carine Premand, Carine Gaiser, Tanja Kluser, Eric Kübler, Laura Suter-Dick. Exosomal microRNAs Release as a Sensitive Marker for Drug-Induced Liver InjuryIn VitroApplied In Vitro Toxicology 2020; 6(3): 77 doi: 10.1089/aivt.2020.0008
149
Jorge-Shmuel Delgado. Evolving trends in nonalcoholic fatty liver diseaseEuropean Journal of Internal Medicine 2008; 19(2): 75 doi: 10.1016/j.ejim.2007.02.034
150
Mario Plebani, Daniela Basso. Non-invasive assessment of chronic liver and gastric diseasesClinica Chimica Acta 2007; 381(1): 39 doi: 10.1016/j.cca.2007.02.019
151
Hakan Fotbolcu, Elçin Zorlu. Nonalcoholic fatty liver disease as a multi-systemic diseaseWorld Journal of Gastroenterology 2016; 22(16): 4079-4090 doi: 10.3748/wjg.v22.i16.4079
152
M. H. JARRAR, A. BARANOVA, R. COLLANTES, B. RANARD, M. STEPANOVA, C. BENNETT, Y. FANG, H. ELARINY, Z. GOODMAN, V. CHANDHOKE, Z. M. YOUNOSSI. Adipokines and cytokines in non-alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics 2007; 27(5): 412 doi: 10.1111/j.1365-2036.2007.03586.x
153
T. Poynard. Faut-il encore faire des biopsies du foie ?La Revue de Médecine Interne 2007; 28(2): 67 doi: 10.1016/j.revmed.2006.09.003
154
Charles S. Lieber, David G. Weiss, Fiorenzo Paronetto. Value of Fibrosis Markers for Staging Liver Fibrosis in Patients With Precirrhotic Alcoholic Liver DiseaseAlcoholism: Clinical and Experimental Research 2008; 32(6): 1031 doi: 10.1111/j.1530-0277.2008.00664.x
155
Mortada Hassan El-Shabrawi, Mona Isa. Noninvasive Methods to Evaluate Liver Fibrosis in Chronic HCV InfectionHepatitis Monthly 2011; 11(9): 758 doi: 10.5812/kowsar.1735143X.1377
156
Daiki Suzuki, Yoshitomo Matsumi, Kouhei Ohnishi. An analysis on force data during biopsy insertion2014 IEEE 13th International Workshop on Advanced Motion Control (AMC) 2014; : 422 doi: 10.1109/AMC.2014.6823319
157
Ancha Baranova, Priyanka Lal, Aybike Birerdinc, Zobair M Younossi. Non-Invasive markers for hepatic fibrosisBMC Gastroenterology 2011; 11(1) doi: 10.1186/1471-230X-11-91
158
Olga H. Orasan, Mihaela Iancu, Madalina Sava, Aniela Saplontai-Pop, Angela Cozma, Simina Tarmure Sarlea, Corneliu Lungoci, Marius-Ionut Ungureanu, Vasile Negrean, Dorel Sampelean, Dan Lucian Dumitrascu. Non-invasive assessment of liver fibrosis in chronic viral hepatitisEuropean Journal of Clinical Investigation 2015; 45(12): 1243 doi: 10.1111/eci.12543
159
Mustafa Kula, Seyhan Karacavus, Mevlut Baskol, Kemal Deniz, Ummuhan Abdulrezzak, Ahmet Tutus. Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of fibrosis in chronic hepatitis: histopathological correlationNuclear Medicine Communications 2010; 31(4): 280 doi: 10.1097/MNM.0b013e328334bff7
160
Laurent Castera. Assessing liver fibrosisExpert Review of Gastroenterology & Hepatology 2008; 2(4): 541 doi: 10.1586/17474124.2.4.541
161
Giada Sebastiani, Kostas Pantopoulos. Disorders associated with systemic or local iron overload: from pathophysiology to clinical practiceMetallomics 2011; 3(10): 971 doi: 10.1039/c1mt00082a
162
Nermin N. Salkic, Elmir Cickusic, Predrag Jovanovic, Mirela Basic Denjagic, Samra Iljazovic-Topcic, Milenko Bevanda, Sead Ahmetagic. Online combination algorithm for non-invasive assessment of chronic hepatitis B related liver fibrosis and cirrhosis in resource-limited settingsEuropean Journal of Internal Medicine 2015; 26(8): 628 doi: 10.1016/j.ejim.2015.07.005
163
Jerome Lambert, Philippe Halfon, Guillaume Penaranda, Pierre Bedossa, Patrice Cacoub, Fabrice Carrat. How to Measure the Diagnostic Accuracy of Noninvasive Liver Fibrosis Indices: The Area Under the ROC Curve RevisitedClinical Chemistry 2008; 54(8): 1372 doi: 10.1373/clinchem.2007.097923
164
Sreelakshmi Kotha, ShuetFong Neong, Keyur Patel. Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinomaExpert Review of Molecular Diagnostics 2018; 18(8): 713 doi: 10.1080/14737159.2018.1496020
165
Mustafa Cengiz, Seren Ozenirler. Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2015; 27(11): 1293 doi: 10.1097/MEG.0000000000000445
166
Manuel Romero-Gómez, Emilio Gómez-González, Ana Madrazo, Marina Vera-Valencia, Luis Rodrigo, Ramón Pérez-Alvarez, Rosa Pérez-López, Victor M. Castellano-Megias, Manuel Nevado-Santos, Juan C. Alcón, Ricard Solá, José M. Pérez-Moreno, José M. Navarro, Raúl J. Andrade, Javier Salmerón, Manuel Fernández-López, Rafael Aznar, Moisés Diago. Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis CHepatology 2008; 47(3): 810 doi: 10.1002/hep.22112
167
Laurent Castera. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver diseaseBest Practice & Research Clinical Gastroenterology 2011; 25(2): 291 doi: 10.1016/j.bpg.2011.02.003
168
Thierry Poynard, Victor de Ledinghen, Jean-Pierre Zarski, Carol Stanciu, Mona Munteanu, Julien Vergniol, Julie France, Anca Trifan, Joseph Moussalli, Pascal Lebray, Dominique Thabut, Vlad Ratziu. FibroTest® and Fibroscan® performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rateClinics and Research in Hepatology and Gastroenterology 2011; 35(11): 720 doi: 10.1016/j.clinre.2011.07.003
169
T. Poynard, Y. Ngo, P. Marcellin, S. Hadziyannis, V. Ratziu, Y. Benhamou. Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virusJournal of Viral Hepatitis 2009; 16(3): 203 doi: 10.1111/j.1365-2893.2008.01065.x
170
María Eugenia Constantino. Naturaleza y grafía. El <em>corpus</em> documental de las colecciones animales en el Real Gabinete de Madrid, 1752-1790Asclepio 2015; 67(2): p110 doi: 10.3989/asclepio.2015.28
171
Measurement of Soft Tissue Elasticity in Vivo2015; : 156 doi: 10.1201/b19032-13
172
Patrick Ingiliz, Kim Pav Chhay, Mona Munteanu, Pascal Lebray, Yen Ngo, Dominique Roulot, Yves Benhamou, Dominique Thabut, Vlad Ratziu, Thierry Poynard. Applicability and variability of liver stiffness measurements according to probe positionWorld Journal of Gastroenterology 2009; 15(27): 3398-3404 doi: 10.3748/wjg.15.3398
173
Xie Er Liang, Chunxiu Zhong, Liwen Huang, Shuling Yang, Youfu Zhu, Yongpeng Chen, Jinlin Hou. Optimization of hepatitis B cirrhosis detection by stepwise application of transient elastography and routine biomarkersJournal of Gastroenterology and Hepatology 2017; 32(2): 459 doi: 10.1111/jgh.13475
174
Yong-Peng Chen, Jie Peng, Jin-Lin Hou. Non-invasive assessment of liver fibrosis in patients with chronic hepatitis BHepatology International 2013; 7(2): 356 doi: 10.1007/s12072-013-9439-y
175
V. RATZIU, P. GIRAL, M. MUNTEANU, D. MESSOUS, A. MERCADIER, M. BERNARD, R. MORRA, F. IMBERT-BISMUT, E. BRUCKERT, T. POYNARD. Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemiaAlimentary Pharmacology & Therapeutics 2006; 25(2): 207 doi: 10.1111/j.1365-2036.2006.03182.x